Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $76,888 | 38 | 99.3% |
| Education | $475.00 | 1 | 0.6% |
| Travel and Lodging | $24.75 | 3 | 0.0% |
| Food and Beverage | $16.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $77,388 | 42 | $0 (2024) |
| ABBVIE INC. | $16.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,183 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($49,183) |
| 2023 | $19,187 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($19,170) |
| 2022 | $9,035 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($9,035) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $563.33 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $8.25 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,496.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $563.33 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 1,365 | 1,468 | $1.2M | $131,001 |
| 2022 | 7 | 732 | 775 | $566,262 | $67,957 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 570 | 613 | $778,941 | $83,420 | 10.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 163 | 167 | $273,217 | $27,982 | 10.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 163 | 169 | $144,348 | $15,693 | 10.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 455 | 505 | $32,443 | $3,169 | 9.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 14 | 14 | $6,188 | $737.50 | 11.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 280 | 293 | $361,269 | $43,261 | 12.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 101 | 101 | $84,537 | $9,789 | 11.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 52 | $82,316 | $9,457 | 11.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 41 | 42 | $18,564 | $2,452 | 13.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 220 | 248 | $15,128 | $1,607 | 10.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 24 | $3,398 | $927.35 | 27.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 15 | $1,050 | $462.55 | 44.1% |
About Dr. Alex Hamidi, DO
Dr. Alex Hamidi, DO is a General Practice healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2019. The National Provider Identifier (NPI) number assigned to this provider is 1760945513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alex Hamidi, DO has received a total of $77,404 in payments from pharmaceutical and medical device companies, with $49,183 received in 2024. These payments were reported across 43 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($76,888).
As a Medicare-enrolled provider, Hamidi has provided services to 2,097 Medicare beneficiaries, totaling 2,243 services with total Medicare billing of $198,958. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Emergency Medicine
- Location Williamsburg, VA
- Active Since 04/09/2019
- Last Updated 11/19/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1760945513
Products in Payments
- DALVANCE (Drug) $16.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Williamsburg
Dr. Robert Morrison, Dmd, DMD
General Practice — Payments: $8,380
Michael Shuck, D.d.s, D.D.S
General Practice — Payments: $4,933
Dr. Dillon Reed, Dmd, DMD
General Practice — Payments: $3,262
Dr. Kayla Fields
General Practice — Payments: $2,350
Dr. Ana Maya Adkins, Dmd, DMD
General Practice — Payments: $2,065
Dr. Anisha Patel, D.d.s, D.D.S
General Practice — Payments: $1,964